Pharsight

1. List of Cerdelga drug patents

Application	Filing Date	Opposition Party	Legal Status
EP16175117A	2020-05-14	Accord Healthcare Ltd	Granted and Under Opposition
EP16175117A	2020-05-14	Hetero Labs Limited	Granted and Under Opposition
EP16175117A	2020-05-13	Teva Pharmaceutical Industries Ltd	Granted and Under Opposition
EP10785289A	2015-02-27	SANDOZ AG	Patent maintained as amended

Patent	Proceeding Filing Date	Status	Respondent	Petitioner
US11458119	November, 2020	Decision	Hanlan Liu et al.
US10888547	April, 2019	Decision	Genzyme Corporation

Patent Number	Company	Patent Title	Patent Expiry
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US6916802	GENZYME CORP	Amino ceramide-like compounds and therapeutic methods of use	Apr, 2022 (1 year, 30 days ago)
US7196205	GENZYME CORP	Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors	Jun, 2026 (3 years from now)
US11458119	GENZYME CORP	Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase	Nov, 2030 (7 years from now)
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7615573	GENZYME CORP	Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors	Apr, 2022 (1 year, 30 days ago)
US7253185	GENZYME CORP	Amino ceramide-like compounds and therapeutic methods of use	Apr, 2022 (1 year, 30 days ago)
US10888547	GENZYME CORP	Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase	Jan, 2031 (7 years from now)
US10888544	GENZYME CORP	Methods for treating Gaucher disease	Dec, 2038 (15 years from now)

Do you want to check out CERDELGA patents from before 2022?

Market Authorisation Date: 19 August, 2014

Treatment: Treatment of gaucher disease type 1; Long-term treatment of adults with gaucher disease type 1 who are cyp2d6 poor metabolizers with 84 mg once daily of eliglustat (equivalent to 100 mg of eliglustat ...

Dosage: CAPSULE;ORAL